Valuation: Boston Scientific Corporation

Market Cap 75.11B 64.85B 60.84B 55.41B 104B 7,182B 106B 713B 279B 3,598B 282B 276B 11,969B P/E 2026 *
19.4x
P/E 2027 * 20.1x
Enterprise Value 83.83B 72.37B 67.9B 61.84B 116B 8,015B 118B 796B 312B 4,016B 315B 308B 13,358B EV / Sales 2026 *
3.92x
EV / Sales 2027 * 3.61x
Free-Float
82.49%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week+2.08%
Current month+10.23%
1 month+16.99%
3 months-7.89%
6 months-32.48%
Current year-45.98%
1 week 50.02
Extreme 50.02
52.99
1 month 42.5
Extreme 42.5
52.99
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Other

Controller/Auditor

2,930 0.0002%
10/08/26 Other

Chief Financial Officer

9,908 0.0007%
05/08/26 Buy

Director

2,100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%+2.08%-50.01%+1.12% 75.11B
-0.43%-2.21%+20.28%+9.42% 218B
-0.34%-3.42%-3.25%-20.02% 142B
-0.95%-0.37%-18.56%+35.11% 139B
-0.94%-1.22%+16.10%+18.32% 52.8B
-0.79%-0.43%-17.43%-15.38% 50.66B
+0.10%-0.03%+25.83%+23.02% 41.95B
-1.18%-1.29%+40.45%+48.80% 40.49B
-1.72%-0.63%-0.94%+5.98% 33.28B
-1.88%+0.21%-22.93%+33.81% 32.38B
Average -0.92%+2.04%-1.05%+14.02% 82.59B
Weighted average by Cap. -0.72%+1.31%-0.58%+10.41%

Financials

2026 *2027 *
Net sales 21.37B 18.45B 17.3B 15.76B 29.64B 2,043B 30.05B 203B 79.49B 1,023B 80.22B 78.48B 3,405B 22.34B 19.28B 18.09B 16.48B 30.98B 2,136B 31.41B 212B 83.1B 1,070B 83.86B 82.05B 3,559B
Net income 3.84B 3.32B 3.11B 2.84B 5.33B 367B 5.4B 36.49B 14.3B 184B 14.43B 14.12B 612B 3.74B 3.23B 3.03B 2.76B 5.19B 357B 5.26B 35.5B 13.91B 179B 14.04B 13.73B 596B
Net Debt 8.72B 7.53B 7.06B 6.43B 12.09B 833B 12.26B 82.76B 32.43B 418B 32.73B 32.02B 1,389B 5.45B 4.71B 4.42B 4.02B 7.56B 521B 7.67B 51.76B 20.28B 261B 20.47B 20.02B 869B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
17/08/26 $51.51 -0.62% 8,837,822
14/08/26 $51.83 +0.27% 16,297,739
13/08/26 $51.69 +0.53% 15,699,989
12/08/26 $51.42 +0.45% 20,673,074
11/08/26 $51.19 +1.45% 13,453,112
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
51.83USD
Average target price
62.69USD
Spread / Average Target
+20.95%

Quarterly revenue - Rate of surprise